Skip to main content

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

Active, not recruiting · Not applicable · NCT04192591

Conditions: Lumbar Spinal Stenosis

At a glance

Research payments reported, 2025
$82,143
U.S. investigators named
13
Sites paid
13
Planned or actual enrollment
166

About the trial

Sponsor
Boston Scientific Corporation
Tested
Superion™ IDS device (device)
Dates
Started 2020-01-30; completion 2041-02
Results posted
Not yet

To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

From ClinicalTrials.gov, last updated 2026-10-09. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Boston Scientific Corporation reported $82,143 in research payments for this study in 2025 (53 payments).

Products named: Precision

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.